ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

General Practice

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

16,516Medicare Part D Prescriptions Filled, Including Refills

Rank: 44 out of 457

$964K Total Retail Price of All Prescriptions

Rank: 50 out of 457

293 Patients Receiving at Least One Drug in Part D
87%Patients 65 Years and Older
81% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Florida
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

N/A

Risky Drugs to Seniors

1% of this provider’s 15,188 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

33% of this provider’s prescriptions were for brand-name drugs, compared to an average of 28%.

Prescription Price

$58 was the average price of a prescription from this provider, compared to $62 among peers.

Prescriptions per Patient

56 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Florida
CRESTOR 570 505 1 9
ALENDRONATE SODIUM 455 395 2 16
DIOVAN 443 404 3 30
CILOSTAZOL 425 374 4 88
LISINOPRIL 412 378 5 3
OMEPRAZOLE 404 376 6 1
LEVOTHYROXINE SODIUM 364 335 7 5
GABAPENTIN 362 342 8 15
GLIPIZIDE 342 299 9 42
FENOFIBRATE 307 278 10 46
IBUPROFEN 291 261 11 14
METFORMIN HCL 290 276 12 6
LOVASTATIN 276 266 13 25
NEXIUM 268 266 14 12
ZOLPIDEM TARTRATE 267 250 15 13
FUROSEMIDE 261 228 16 10
METOPROLOL SUCCINATE 255 210 17 21
HYDROCHLOROTHIAZIDE 248 227 18 8
LABETALOL HCL 247 231 19 215
NAMENDA 239 227 20 32
PENTOXIFYLLINE 233 207 21 67
ALLOPURINOL 229 213 22 47
METOPROLOL TARTRATE 225 222 23 7
RANITIDINE HCL 225 196 23 17
DONEPEZIL HCL 225 215 23 22
VERAPAMIL HCL 218 218 10 26 288
LOSARTAN POTASSIUM 217 202 27 18
CLOPIDOGREL 189 180 28 19
SINGULAIR 183 165 29 43
POTASSIUM CHLORIDE 180 143 30 28
DILTIAZEM HCL 162 150 31 260
MECLIZINE HCL 158 145 32 55
PLAVIX 158 146 32 24
ATENOLOL 151 141 34 11
ESCITALOPRAM OXALATE 139 135 35 61
BENICAR 139 126 35 90
FAMOTIDINE 133 130 37 62
NIASPAN 131 127 38 169
FOLIC ACID 126 126 39 81
CREON 121 110 40 209
ADVAIR DISKUS 117 108 41 27
ALPRAZOLAM 115 115 42 39
TRILIPIX 114 97 43 238
LOVAZA 114 114 43 50
CLONIDINE HCL 111 111 45 52
NIFEDIPINE ER 105 105 46 89
AMITRIPTYLINE HCL 105 89 R 46 156
DIOVAN HCT 100 100 48 51
ZETIA 97 95 49 137
AVAPRO 97 89 49 304
MONTELUKAST SODIUM 96 91 51 86
CARVEDILOL 91 75 52 20
AMLODIPINE BESYLATE 89 84 53 4
AVODART 86 86 54 110
PRAVASTATIN SODIUM 86 75 54 29
RIVASTIGMINE 85 78 56 400
INSULIN SYRINGE 85 70 56 79
WARFARIN SODIUM 84 77 58 38
NATEGLINIDE 80 80 59 270
CELEBREX 80 68 59 53
TAMSULOSIN HCL 76 69 61 36
SIMVASTATIN 71 70 62 2
DOXAZOSIN MESYLATE 69 68 63 73
LIDODERM 62 48 64 31
AMLODIPINE BESYLATE-BENAZEPRIL 61 61 65 72
VOLTAREN 60 54 66 34
CALCITONIN-SALMON 60 60 66 285
DILTIAZEM 24HR CD 59 57 68 232
MUPIROCIN 59 55 68 91
LANTUS 56 43 70 56
CEPHALEXIN 53 49 71 188
LEXAPRO 51 50 72 138
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on April 5, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.